Jeff Nelson
Chief Operating Officer chez MILESTONE PHARMACEUTICALS INC.
Fortune : - $ au 31/03/2024
Profil
Jeff Nelson is currently the Chief Operating Officer at Milestone Pharmaceuticals, Inc. He previously worked as the Vice President-Program Management at Oncotelic Therapeutics, Inc. from 2015 to 2017, and as the Head-Clinical Operations at Axsome Therapeutics, Inc. from 2014 to 2015.
Mr. Nelson completed his undergraduate degree at Brandeis University in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jeff Nelson
| Sociétés | Poste | Début |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Chief Operating Officer | 01/06/2020 |
Anciens postes connus de Jeff Nelson
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Formation de Jeff Nelson
| Brandeis University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| AXSOME THERAPEUTICS, INC. | Health Technology |
